The study was conducted by evaluating two kind combination protocols: the P1 formula (including Hib antigen, diphtheria monolithic antigen, whole cell pertussis, tetanus, hepatitis B and P2 formula (including Hib antigen, diphtheria monolithic antigen, acellular pertussis, tetanus, hepatitis B).